US-Canada joint inspection pilot shows savings of time-in-facility
This article was originally published in RAJ Devices
A US-Canada pilot programme involving joint quality systems inspections of medical device companies by a single third party has revealed that around 33% less total time is spent at a manufacturer's facility when compared to the combined time of inspections performed individually to satisfy the regulatory requirements of each country1,2.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.